Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent
NCT00002029
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Fat Emulsion 2%
DRUG:
Fat Emulsion 20%
Sponsor
Abbott